Approval · Notice of Compliance 35233 · 2025
ONPATTRO: Notice of Compliance 35233
Issued April 23, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35233
- Date
- April 23, 2025
- Company
- Alnylam Netherlands B.V.Amsterdam, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONPATTRO | Not yet assigned | — |
Medicinal ingredients
- PATISIRAN SODIUM 2 MG per ML